Conversion from tacrolimus to Neoral in liver and kidney transplant recipients.
Ott
R
R
Department of Surgery, University of Erlangen, Erlangen, Germany.
Bussenius-Kammerer
M
M
Scholz
D
D
Neuhaus
R
R
Tolba
R H
RH
Fricke
L
L
Müller
V
V
D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D016559:Tacrolimus